Contact us contattaci
logo
logo

Investors Area

fe.data_usage

Captcha non valido!

Investors

Annual Balance

  • 2022 - Audit opinion – 29/04/2023
    Download
  • Annual Consolidated Financial Report, 2022 – 29/04/2023
    Download

Quarter Reports

  • Kepler Spa Interim Report 2023 – Q3 – 29/11/2023
    Download
  • Kepler Spa Interim Report 2023 – H1 – 29/08/2023
    Download
  • Kepler Spa Interim Report 2023 - Q1 – 29/05/2023
    Download
  • Kepler Spa Interim Report 2022 - Q3 – 28/11/2022
    Download
  • Kepler Spa Interim Report 2022 – H1 – 27/09/2022
    Download
  • Kepler Spa Interim Report 2022 – Q1 – 29/06/2022
    Download

Presentations and Documents

  • Kepler SpA - Q3-23 Investor Presentation – 11/12/2023
    Download
  • Kepler S.p.A. - H1-23 Investor Presentation – 05/09/2023
    Download
  • Kepler SpA – Q1-23 Investor Presentation – 08/06/2023
    Download
  • Kepler SpA – FY-22 Investor Presentation – 12/05/2023
    Download
  • BNP Paribas Annual High Yield & Leveraged Finance Conference 2023 Presentation – 18/01/2023
    Download
  • Kepler SpA – 3Q-22 Investor Presentation – 06/12/2022
    Download
  • Kepler SpA – H1-22 Investor Presentation – 11/10/2022
    Download
  • Kepler SpA – Q1-22 Investor Presentation – 14/07/2022
    Download

Contacts

If you have any questions, information requests or would like to discuss your business requirements in person, please feel free to get in touch or request a call back.

Chief Executive Officer
Gianfranco Nazzi

Chief Financial Officer
Morris Maracin

Email: [email protected]

logo
© Biofarma Srl C.F. and P.IVA 02895910301
T. +39 0432 868711 F. +39 0432 868018
Via Castelliere, 2
33036 Mereto di Tomba (UD) Italy
Number REA UD - 296214
Date of entry in the
Business Register of UDINE: 01/07/2017
Registration number: 02895910301
Share capital euro 3.000.000